Willy Ssengooba, Emmanuel Musisi, Derrick Semugenze, Kevin Komakech, Moses Ndema, Christine Sekaggya-Wiltshire et al. Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment. // BMC Infectious Diseases. – 2025. – DOI: 10.1186/s12879-025-11785-7. – URL: https://doi.org/10.1186/s12879-025-11785-7
Willy Ssengooba, Emmanuel Musisi, Derrick Semugenze, Kevin Komakech, Moses Ndema, Christine Sekaggya-Wiltshire, Susan Adakun, Derek J. Sloan, Achilles Katamba, Mohammed Lamorde, Moses Joloba, & Wilber Sabiiti (2025). Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-11785-7
Willy Ssengooba, et al. “Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment.” BMC Infectious Diseases, 2025. doi:10.1186/s12879-025-11785-7.
@article{Ssengooba2025,
title = {Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment},
author = {Ssengooba, Willy and Musisi, Emmanuel and Semugenze, Derrick and Komakech, Kevin and Ndema, Moses and Sekaggya-Wiltshire, Christine and Adakun, Susan and Sloan, Derek J. and Katamba, Achilles and Lamorde, Mohammed and Joloba, Moses and Sabiiti, Wilber},
journal = {BMC Infectious Diseases},
year = {2025},
doi = {10.1186/s12879-025-11785-7},
url = {https://doi.org/10.1186/s12879-025-11785-7}
}